Cystic fibrosis is a risk factor for celiac disease

Acta Biochimica Polonica

Volumn 57, Issue 1, 2010, Pages 115-118

  Walkowiak, Jarosław ^b   Blask Osipa, Anna ^a   Lisowska, Aleksandra ^a   Oralewska, Beata ^c   Pogorzelski, Andrzej ^d   Cichy, Wojciech ^a   Sapiejka, Ewa ^e   Kowalska, Mirosława ^f   Korzon, Michał ^g   Szaflarska Popławska, Anna ^h  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POZNA UNIVERSITY OF LIFE SCIENCES   (Poland)

^c CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^d Department of Bronchology and Cystic Fibrosis   (Poland)

^e Out Patient Clinic for CF Patients   (Poland)

^f Out Patient Clinic for Patients with Pulmonary Diseases Panaceum   (Poland)

^g MEDICAL UNIVERSITY OF GDANSK   (Poland)

^h NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Antiendomysial antibodies; Celiac disease; Cystic fibrosis; Genetic predisposition

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CHILD; CYSTIC FIBROSIS; FEMALE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HUMAN; MALE; PRESCHOOL CHILD; RISK FACTOR;

ADOLESCENT; ADULT; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; RISK FACTORS; YOUNG ADULT;

EID: 77953265805     PISSN: 0001527X     EISSN: 1734154X     Source Type: Journal    
DOI: 10.18388/abp.2010_2382     Document Type: Article

References (35)

1. Bignon JD, Fernandez-Vina MA (1997) Protocols of 12th IHW for typing of HLA class II alleles by DNA amplification by the polymerase chain reaction (PCR) and hybridization with sequence specific oligonucleotide probes (SSOP). In Genetic diversity of HLA. Functional and medical implication. Charron D ed, pp 203-204. Paris.
2. Borowitz D, Durie PR, Clarke LL, Werlin SL, Taylor CJ, Semler J, De Lisle RC, Lewindon P, Lichtman SM, Sinaasappel M, Baker RD, Baker SS, Verkade HJ, Lowe ME, Stallings VA, Janghorbani M, Butler R, Heubi J (2005) Gastrointestinal outcomes and confounders in cystic fibrosis. J Pediat Gastroenterol Nutr 41: 273-285.
3. Bossuyt X, Blanckaert N (1999) Evaluation of interferences in rate and fixed-time nephelometric assays of specific serum proteins. Clin Chem 1: 62-67.
4. Bruzzesse E, Raia V., Gaudiello G., Polito G., Buccigrossi V., Fornicola V (2004) Intestinal inflammation is a frequent feature of cystic fibrosis and is reduced by probiotic administration. Aliment Pharmacol Ther 20: 813-819.
5. Chorzelski TP, Buetner EH, Sulej J (1984) IgA anti-endomysium antibody. A new immunological marker of dermatitis herpetiformis and celiac disease. Br J Dermatol 111: 395-402.
6. Cox KL, Isenberg JN, Ament ME (1982) Gastric acid hypersecrection in cystic fibrosis. J Pediatr Gastroenterol Nutr 1: 559-565.
7. Di Sabatino A, Corazza GR (2009) Coeliac disease. Lancet 373: 1480-1493.
8. Dietrich W, Ehinis T, Bauer M (1997) Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 3: 797-801.
9. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S, Elitsur Y, Green PH, Guandalini S, Hill ID, Pietzak M, Ventura A, Thorpe M, Kryszak D, Fornaroli F, Wasserman SS, Murray JA, Horvath K (2003) Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 163: 286-292.
10. Fluge G, Olesen HV, Gilljam M, Meyer P, Pressler T, Storrösten OT (2009) Co-morbidity of cystic fibrosis and celiac disease in Scandinavian cystic fibrosis patients. J Cyst Fibros 8: 198-202.
11. Hed J, Lieden G, Ottosson E, Ström M, Walan A, Groth O, Sjögren F, Franzen L (1986) IgA antigliadin antibodies and jejunal mucosal lesions in healthy blood donors. Lancet 11: 215.
12. Hendriks HJ, van Kreel B, Forget PP (2001) Effects of therapy with lansoprazole on intestinal permeability and inflammation in young cystic fibrosis patients. J Pediatr Gastroenterol Nutr 33: 260-265.
13. Hovdenak N, Hovlid E, Aksnes L, Fluge G, Ericgsen MM, Eide J (1999) High prevalence of asymptomatic celiac disease in Norway: a study of blood donors. Eur J Gastroenterol Hepatol 11: 185-187.
14. Ivarsson A, Persson LA, Juto P, Peltonen M, Suhr O, Hernell O (1999) High prevalence of undiagnosed coeliac disease in adults: a Swedish population-based study. J Intern Med 245: 63-68.
15. Leclercq-Foucart J, Forget P, Van Cutsem JL (1987) Lactulose rhamnose intestinal permeability in children with cystic fibrosis. J Pediatr Gastroenterol Nutr 6: 66-70.
16. Lisowska A, Wójtowicz J, Walkowiak J (2009) Small intestine bacterial overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection. Acta Biochim Pol 56: 631-634.
17. Lohi S, Mustalahti K, Kaukinen K, Laurila K, Collin P, Rissanen H, Lohi O, Bravi E, Gasparin M, Reunanen A, Mäki M (2007) Increasing prevalence of celiac disease over time. Aliment Pharmacol Ther 26: 1217-1225.
18. Maki M, Mustalahiti K, Kokkonen J, Kulmala P, Haapalahti M, Karttunen T, Ilonen J, Laurila K, Dahlbom I, Hansson T, Höpfl P, Knip M (2003) Prevalence of celiac disease among children in Finland. N Engl J Med 348: 2517-2524.
19. Marsh MN (1992) Gluten, major histocompatibility complex, and the small intestine. A molecular and immunologic approach to the spectrum of gluten sensitivity (celiac spurue). Gastroenterology 102: 330-354.
20. Murphy MS, Sheldon W, Brunetto A, Pearson AD, Laker MF, Eastham EJ, Nelson R (1989) Active and passive sugar absorption in pancreatic insufficiency. J Pediatr Gastroenterol Nutr 8: 189-194.
21. Norkina O, Kaur S, Ziemer D, De Lisle RC (2004) Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286: 1032-1041.
22. Oberhuber G, Granditsch G, Vogelsang H (1999) The histopatopathology of celiac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11: 1185-1194.
23. Pardo F (1991) Coesistenza di malattia celiaca e di fibrosi cistica. Descrizione di un caso clinico. Riv Ital Pediatr 17: 614.
24. Raia V, Maiuri L, De Ritis G, de Vizia B, Vacca L, Coute R (2000) Evidence of chonic inflammation in morphologically normal small intestine of cystic fibrosis patients. Pediatr Res 47: 344-350.
25. Smyth RL, Croft NM, O'Hea U, Marshall TG, Ferguson A (2000) Intestinal inflammation in cystic fibrosis. Arch Dis Child 82: 394-399.
26. Sollid LM, Lie BA (2005) Celiac disease genetics: current concepts and practical applications. Clin Gastroenterol Hepatol 3: 843-851.
27. Sollid LM, Markussen G, Ek J, Gjerde H, Vartdal F, Thorsby E (1989) Evidence for a primary association of celiac disease to a particular HLA-DQ alpha/beta heterodimer. J Exp Med 169: 345-350.
28. Szaflarska-Popławska A, Parzecka M, Müller L, Placek W (2009) Screening for celiac disease in Poland. Med Sci Monit 15: PH7-PH11.
29. Tommasini A, Not T, Kiren V, Baldas V, Santon D, Trevisiol C, Berti I, Neri E, Gerarduzzi T, Bruno I, Lenhardt A, Zamuner E, Spanò A, Crovella S, Martellossi S, Torre G, Sblattero D, Marzari R, Bradbury A, Tamburlini G, Ventura A (2004) Mass screening for coeliac disease using antihuman transglutaminase antibody assay. Arch Dis Child 89: 512-515.
30. Valleta EA, Mastella G (1989) Incidence of celiac disease in a cystic fibrosis population. Acta Paediatr Scand 78: 784-785.
31. Venuta A, Bertolani P (1999) Coexistence of cystic fibrosis and celiac disease. Description of a clinical case and reviev of the literature. Pediatr Med Chir 21: 223-226.
32. Walkowiak J, Nousia-Arvanitakis S, Henker J, Stern M, Sinaasappel M, Dodge JA (2005) Indirect pancreatic tests in children. J Pediatr Gastroenterol Nutr 40: 107-114.
33. Walkowiak J, Sands D, Nowakowska A, Piotrowski R, Zybert K, Herzig KH, Milanowski A (2005) Early decline of pancreatic function in cystic fibrosis patients with lass 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr 40: 199-201.
34. Weile B, Godzinsky E, Skogh T, Jordal R, Cavell B, Krasilnikoff PA (1996) Screening Danish blood donors for antigliadin and antiendomysium antibodies. Acta Pediatr (Suppl) 412: 46.
35. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, Reader R, Holmes GK, Khaw KT (2003) Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 52: 960-965.